Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain.

Front Pharmacol · 2021 · PMC8809372 · PMID 35126148

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Proximal and distal recordings of NCV and APA exhibited a decreasing trend for increasing concentrations of bortezomib.

also in 47,180 other papers

showed a trendno p-value reported

Treatment with dexanabinol showed a trend toward improving the bortezomib-induced decrease of IENF density, although these changes were not statistically significant ( Figure 6 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.